Galectin Therapeutics Inc.

NASDAQ:GALT

1.15 (USD) • At close January 14, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000
Omzet 000000000000000000000000
Kosten van de omzet 0.0330.0320.0410.0360.03500.0010.0070.0070000005.3266.4557.048000000
Brutowinst -0.033-0.032-0.041-0.036-0.0350-0.001-0.007-0.007000000-5.326-6.455-7.048000000
Brutowinstmarge 000000000000000000000000
Onderzoek- en ontwikkelingskosten 32.1331.73723.81817.9767.4676.47111.72115.32513.1148.4255.6884.5273.5521.0661.111.7742.0533.0193.043.0421.951.4830.8930.1
Algemene en administratieve kosten 5.8986.6156.3615.4685.9717.1314.5266.1566.9657.0056.4165.3726.8573.8174.9833.5524.4024.0293.6154.2622.9881.8041.2890.07
Verkoop- en marketingkosten 0.04400000000000000000000000
Verkoop-, algemene en administratieve kosten 5.9426.6156.3615.4685.9717.1314.5266.1566.9657.0056.4165.3726.8573.8174.9833.5524.4024.0293.6154.2622.9881.8041.2890.07
Overige kosten -000000000000.2000000000000
Bedrijfskosten 38.07238.35230.17923.44413.43813.60216.24721.48120.07915.4312.1049.89910.4094.8836.0935.3266.4557.0486.6557.3044.9383.2872.1820.17
Bedrijfsresultaat -38.072-38.352-30.179-23.444-13.438-13.602-16.247-21.481-20.079-15.43-12.104-9.899-10.409-4.883-6.093-5.326-6.455-7.048-6.655-7.304-4.938-3.287-2.182-0.17
Bedrijfsresultaat ratio 000000000000000000000000
Totaal overige inkomsten en kosten netto -2.994-0.424-0.348-0.0210.144-0.2980.0120.0450.052-0.3580.0160.224-0.506-0.746-1.3692.175-2.9783.8550.1110.1240.065-0.3910-0.02
Inkomen voor belasting -41.066-38.776-30.527-23.465-13.294-13.9-16.235-21.436-20.027-15.788-12.088-9.675-10.915-5.629-7.462-3.151-9.433-3.193-6.544-7.18-4.873-3.6780-0.19
Inkomen voor belasting ratio 000000000000000000000000
Belastingkosten 00.4240.4480.0510.087-0.1230.02400-0.0520.0160.20.5060.7461.369-2.1752.978-3.85500001.7880
Nettowinst -41.066-39.2-30.975-23.516-13.381-13.9-16.235-21.436-20.027-15.788-12.088-9.675-10.915-5.629-7.462-3.151-9.433-3.193-6.544-7.18-4.873-3.678-3.97-0.19
Nettowinstmarge 000000000000000000000000
WPA (Winst Per Aandeel) -0.74-0.66-0.53-0.41-0.26-0.35-0.46-0.73-0.83-0.72-0.72-0.64-0.91-0.6-0.93-0.4-1.45-0.67-1.44-1.67-1.37-1.35-1.75-0.092
Verwaterde WPA -0.74-0.66-0.53-0.41-0.26-0.35-0.46-0.73-0.83-0.72-0.72-0.64-0.91-0.6-0.93-0.4-1.45-0.67-1.44-1.67-1.37-1.35-1.75-0.092
EBITDA -0.202-37.711-29.997-23.342-13.172-13.564-16.234-21.474-20.071-15.778-12.076-9.666-10.906-5.617-7.425-3.102-9.019-1.276-6.773-7.099-4.849-3.076-2.023-0.19
EBITDA ratio 000000000000000000000000